Treating IgG4-related disease with rituximab

from The Rheumatology Podcast · host Oxford University Press

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients after treatment. They discuss the potential implications for future treatment, drawbacks of the study and possible future research directions for the disease.

Episode metadata supplied by the publisher feed · Published May 4, 2026

Embed this episode

Attribution link and audio player

What this episode covers

Dr James Galloway and Dr Justin Mason, discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Treating IgG4-related disease with rituximab

0:00 7:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rheumatology Podcast?

This episode is 7 minutes long.

When was this The Rheumatology Podcast episode published?

This episode was published on May 4, 2026.

Can I download this The Rheumatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!